Tensive
Biomedical Engineering
Overview
Discover Tensive’s innovation in bioresorbable scaffold technologies, advancing breast reconstruction through cutting-edge research, clinical excellence, and scientific leadership.
Funding and backers
Grants
$4.8M
3 grants · CORDIS
Backers
1
CDP Venture Capital
Momentum
15/100
in the news
Last sign of life
1 mo ago
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Sep 3
Took on debt financing $21.6M · Pulse 2.0
Jul 8
Board appointment Tensive appoints Peter Crosby Chairman as its bioresorbable breast reconstruction scaffold approaches regulatory approval · markets.businessinsider.com
Mar 1, 2023
Won a grant $2.7M · CORDIS
Jun 1, 2018
Won a grant $2M · CORDIS
Aug 1, 2016
Won a grant $54k · CORDIS
Tractionpublic signals, read monthly
Web presence
top 27%
of 133.2M domains by links, Common Crawl
Funding rounds
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Life-saving medical devices made with purpose and precision. From cutting-edge catheter systems to custom product development, we leverage…
Myya offers a virtual fitting experience covered by insurance for breast cancer patients to find the perfect mastectomy and post surgery…
We’re using cutting-edge processes to develop a new generation of sugars, high purity hydrolysis lignin, and unique microcrystalline…
SQIM - The Material Innovation company biofabricating biomaterials grown from mycelium through fungal fermentation, valorising waste and…
BellaSeno is advancing regenerative soft-tissue restoration through bioresorbable scaffold technology designed to guide natural tissue…
Jupiter Biomedical Research is a preclinical, IND-enabling biotech advancing two patented oral small-molecule therapeutic candidates…
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
CDP Venture CapitalVia a fund
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
News
Breast implant alternative startup Tensive receives €20 million EIB loan to advance REGENERA
Milan-based MedTech startup Tensive, the developer of REGENERA/SOFTAG bioresorbable scaffolds for breast reconstruction and tissue marking, has recieved a loan of €20 million in order to fund research and development, clinical studies, CE marking, manufac
Read more
Report
Tensive Secures Up To €20 Million EIB Financing To Commercialize Bioresorbable Breast Implant
Tensive has signed a convertible loan agreement with the European Investment Bank for up to €20 million to advance development, regulatory approval, manufacturing scale-up and commercialization of its REGENERA bioresorbable breast implant.
Read more
Report
Medtech, Tensive ottiene 20 milioni di venture debt dalla Bei per protesi al seno all'avanguardia MilanoFinanza News
Le risorse sono fornite con un finanziamento convertibile. I biomateriali avanzati sono destinati a pazienti oncologiche. Fase clinica in corso: prime autorizzazioni previste nel 2027.
Read more
Report
Tensive appoints Peter Crosby Chairman as its bioresorbable breast reconstruction scaffold approaches regulatory approval
Serial entrepreneur Crosby has brought numerous implantable medical devices through CE marking, U.S. FDA approval and commercial launch Joins as T...
Read more
Report
Tensive publishes positive interim pivotal clinical data showing REGENERA supports natural breast reconstruction in Updates in Surgery
Advanced biomaterial device designed for use in lumpectomy surgeries Interim results from the first 25 of 94 patients at 6 months follow upConfirms REGENERA is safe and biocompatible as breast tissue replacement 100% of patients completed adjuvant whole-b
Read more
Report
Tensive Publishes Positive Interim Pivotal Clinical Data Showing REGENERATM Supports Natural Breast Reconstruction In Updates In Surgery
Read more
Report
Tensive reports positive pivotal trial top-line results showing REGENERA bioresorbable device may transform breast reconstruction
Clinical data from pivotal trial in patients undergoing lumpectomy confirm strong safety profile and growing performance benefits Primary safety endpoint met and encouraging secondary performance objectives at 6 months (in 94 patients) and 12 months (in 2
Read more
Report
Tensive annuncia aggiornamenti clinici positivi che evidenziano il potenziale del dispositivo REGENERA / SOFTAG per la ricostruzione del seno post-lumpectomia
I dati clinici provenienti da due studi in corso su pazienti sottoposte a lumpectomia confermano il profilo di sicurezza e i crescenti benefici prestazionali del dispositivo Gli obiettivi primari di sicurezza e secondari di efficacia sono stati raggiunti
Read more
Report
Tensive appointsmedical device veteran Bill Hunter Chairman as its bioresorbable scaffold for breast reconstruction after cancer approaches market
Has more than 30 years of experience bringing innovations to market, including one of the world's first drug-eluting coronary stents at Angiotech PharmaAppointment adds world-class capabilities to Tensive as the company approaches pivotal clinical trial m
Read more
Report
Tensive appointsmedical device veteran Bill Hunter Chairman as its bioresorbable scaffold for breast reconstruction after cancer approaches market
Has more than 30 years of experience bringing innovations to market, including one of the world's first drug-eluting coronary stents at Angiotech PharmaAppointment adds world-class capabilities to Tensive as the company approaches pivotal clinical trial m
Read more
Report
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Milan
Italy
HQ
Location
Via Timavo, 34 20124 Milano (Italy)